Westpac Banking Corp
WBC
CommBank
CBA
Fortescue Ltd
FMG
Rio Tinto Ltd
RIO
National Australia Bank Ltd
NAB
AU Stock MarketDetailed Quotes
IMR Imricor Medical Systems Inc
- 1.170
- +0.075+6.85%
20min DelayMarket Closed Dec 27 16:00 AET
316.11MMarket Cap-5.88P/E (Static)
1.170High1.080Low166.14KVolume1.105Open1.095Pre Close185.62KTurnover1.37552wk High0.08%Turnover Ratio270.18MShares0.41052wk Low-0.17EPS TTM260.35MFloat Cap2.940Historical HighLossP/E (Static)222.52MShs Float0.105Historical Low-0.199EPS LYR8.22%Amplitude--Dividend TTM-30.79P/B1Lot Size--Div YieldTTM
Imricor Medical Systems Inc Key Stats
Quarterly+Annual
YOY
| (FY)Dec 30, 2023 | (FY)Dec 30, 2022 | (FY)Dec 30, 2021 | (FY)Dec 30, 2020 | (FY)Dec 30, 2019 | |
|---|---|---|---|---|---|
| Operating cash flow (direct method) | |||||
| Cash income from operating activities | 21.40%-12.98M | 5.59%-16.51M | -42.99%-17.49M | -84.53%-12.23M | -6.63M |
| Other cash income from operating activities | 21.40%-12.98M | 5.59%-16.51M | -42.99%-17.49M | -84.53%-12.23M | ---6.63M |
| Cash paid | |||||
| Operating cash flow | 21.40%-12.98M | 5.59%-16.51M | -42.99%-17.49M | -84.53%-12.23M | ---6.63M |
| Investing cash flow | |||||
| Cash flow from continuing investing activities | 65.34%-82.78K | 65.65%-238.86K | 10.17%-695.31K | -46.23%-774.03K | -529.34K |
| Net PPE purchase and sale | 65.34%-82.78K | 61.83%-238.86K | 15.65%-625.75K | -103.39%-741.89K | ---364.76K |
| Net investment purchase and sale | ---- | ---- | -116.39%-69.56K | ---32.15K | ---- |
| Net other investing changes | ---- | ---- | ---- | ---- | ---164.58K |
| Cash from discontinued investing activities | |||||
| Investing cash flow | 65.34%-82.78K | 65.65%-238.86K | 10.17%-695.31K | -46.23%-774.03K | ---529.34K |
| Financing cash flow | |||||
| Cash flow from continuing financing activities | 108.29%8.21M | -65.96%3.94M | -64.92%11.59M | 215.98%33.02M | 10.45M |
| Net issuance payments of debt | 10,601.99%2.62M | ---24.97K | ---- | ---- | --3.45M |
| Net common stock issuance | 33.99%5.76M | -64.66%4.3M | -63.58%12.17M | 362.54%33.41M | --7.22M |
| Net other financing activities | 48.44%-171.25K | 42.86%-332.16K | -52.00%-581.3K | -76.24%-382.44K | ---217.01K |
| Cash from discontinued financing activities | |||||
| Financing cash flow | 108.29%8.21M | -65.96%3.94M | -64.92%11.59M | 215.98%33.02M | --10.45M |
| Net cash flow | |||||
| Beginning cash position | -69.28%5.69M | -26.35%18.52M | 397.93%25.14M | 217.87%5.05M | --1.59M |
| Current changes in cash | 62.15%-4.85M | -94.10%-12.81M | -132.95%-6.6M | 507.75%20.02M | --3.29M |
| Effect of exchange rate changes | 57.29%-9.71K | 12.71%-22.74K | -136.74%-26.06K | -57.38%70.93K | --166.4K |
| End cash Position | -85.38%831.52K | -69.28%5.69M | -26.35%18.52M | 397.93%25.14M | --5.05M |
| Free cash from | 22.02%-13.06M | 7.54%-16.75M | -39.64%-18.11M | -85.51%-12.97M | ---6.99M |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |